rx 821002 has been researched along with agmatine in 2 studies
Studies (rx 821002) | Trials (rx 821002) | Recent Studies (post-2010) (rx 821002) | Studies (agmatine) | Trials (agmatine) | Recent Studies (post-2010) (agmatine) |
---|---|---|---|---|---|
317 | 0 | 45 | 940 | 4 | 351 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hussain, JF; Kendall, DA; Pinthong, D; Wilson, VG | 1 |
Assumpció Boronat, M; DeGregorio-Rocasolano, N; García-Sevilla, JA; Gasull, T; Lerma, J; Olmos, G; Paz Regalado, M; Trullas, R; Villarroel, A | 1 |
2 other study(ies) available for rx 821002 and agmatine
Article | Year |
---|---|
Comparison of the interaction of agmatine and crude methanolic extracts of bovine lung and brain with alpha 2-adrenoceptor binding sites.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Agmatine; Animals; Binding, Competitive; Brimonidine Tartrate; Cattle; Cerebral Cortex; Clonidine; Dioxanes; Idazoxan; Imidazoles; Lung; Methanol; Prazosin; Quinoxalines; Receptors, Adrenergic, alpha-2; Yohimbine | 1995 |
Protection by imidazol(ine) drugs and agmatine of glutamate-induced neurotoxicity in cultured cerebellar granule cells through blockade of NMDA receptor.
Topics: Agmatine; Animals; Antazoline; Benzofurans; Cell Line; Cells, Cultured; Cerebellum; Dioxanes; Dizocilpine Maleate; Dose-Response Relationship, Drug; Electrophysiology; Glutamic Acid; Humans; Idazoxan; Imidazoles; Neuroprotective Agents; Patch-Clamp Techniques; Potassium; Radioligand Assay; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Styrenes | 1999 |